Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Abbott Laboratories's Business Segments
Abbott Laboratories's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2025
Reportable Segments
5
Largest Segment
Medical Devices
Total Revenue
$ 11,142
Regions Reported
1
Revenue Share by Reportable Segment - Q2 FY2025
- Medical Devices48.2%
- Nutritional Products19.9%
- Diagnostic Products19.5%
- Established Pharmaceutical Products12.4%
- Corporate and Unallocated0%
Revenue by Reportable Segment - Q2 FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Medical Devices | $ 5,369 | 48.2% |
| Nutritional Products | $ 2,212 | 19.9% |
| Diagnostic Products | $ 2,173 | 19.5% |
2 more segments available
Sign in to unlock the full Abbott Laboratories dataset.
Revenue Share by Region - Q2 FY2025
- Non-US61.6%
Revenue by Geographic Region - Q2 FY2025
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 6,866 | 61.6% |
Description of Abbott Laboratories
Abbott Laboratories operates through five main revenue segments:
1. Pharmaceutical Products: This segment includes the development, manufacture, and marketing of a wide range of prescription medications, primarily focusing on areas such as immunology, neuroscience, cardiology, and metabolic diseases.
2. Diagnostic Products: Abbott offers a comprehensive portfolio of diagnostic tests and systems. This segment provides solutions for healthcare professionals, ranging from laboratory instruments to point-of-care testing across various disease states and conditions.
3. Hospital Products: This segment includes a variety of medical devices and technologies used in hospitals and clinical settings, such as vascular and cardiac devices, as well as technologies for fluid management.
4. Ross Products: This segment focuses on nutrition products, including infant formulas and adult nutritional products, catering to the nutritional needs of various age groups and medical conditions.
5. International: Abbotts international segment encompasses operations outside of the United States, covering all product categories and focusing on expanding access to healthcare and nutrition around the globe.
Additionally, Abbott has a 50-percent owned joint venture, TAP Pharmaceutical Products Inc. which specializes in the development and commercialization of pharmaceutical products.
1. Pharmaceutical Products: This segment includes the development, manufacture, and marketing of a wide range of prescription medications, primarily focusing on areas such as immunology, neuroscience, cardiology, and metabolic diseases.
2. Diagnostic Products: Abbott offers a comprehensive portfolio of diagnostic tests and systems. This segment provides solutions for healthcare professionals, ranging from laboratory instruments to point-of-care testing across various disease states and conditions.
3. Hospital Products: This segment includes a variety of medical devices and technologies used in hospitals and clinical settings, such as vascular and cardiac devices, as well as technologies for fluid management.
4. Ross Products: This segment focuses on nutrition products, including infant formulas and adult nutritional products, catering to the nutritional needs of various age groups and medical conditions.
5. International: Abbotts international segment encompasses operations outside of the United States, covering all product categories and focusing on expanding access to healthcare and nutrition around the globe.
Additionally, Abbott has a 50-percent owned joint venture, TAP Pharmaceutical Products Inc. which specializes in the development and commercialization of pharmaceutical products.
Abbott Laboratories is a diversified global healthcare company that plays a crucial role in enhancing health and wellness through its diverse range of segments and offerings. The company operates across four primary segments: Pharmaceuticals, Diagnostics, Nutritional Products, and Vascular. These segments are developed to meet various health needs, from treating diseases to facilitating diagnostic processes and providing nutritional solutions. Each segment has distinct products and services tailored to address specific healthcare challenges.
1. Pharmaceutical Products
Abbotts Pharmaceutical Products segment is foundational to its operations, offering a broad array of prescription medications for both adults and children. The pharmaceutical portfolio targets key therapeutic areas, including cardiovascular diseases, metabolic disorders, infectious diseases, and neurology.
Key Offerings:
- Cardiovascular Drugs: Abbott has collaborated with AstraZeneca to develop innovative lipid management therapies. Noteworthy products include a fixed-dose combination treatment featuring Crestor® (rosuvastatin) alongside Abbott’s Tricor® (fenofibrate) and the advanced fenofibrate, ABT 335. These therapies focus on managing cholesterol levels to reduce the risk of cardiovascular events.
- Diabetes Care: Abbott has made significant contributions to diabetes management through its range of injectable and oral medications, designed to assist patients with blood sugar control and improve overall metabolic health.
- Immunology and Infectious Diseases: The company provides a spectrum of therapies aimed at managing autoimmune diseases and various infectious diseases, contributing to enhanced patient outcomes in these critical areas.
- Biosimilars and Biologics: Abbott is active in the biosimilars market, working to deliver affordable alternatives to biologic therapies, thus increasing accessibility for patients requiring complex treatments.
Diagnostic Products
Operating as a leader in the diagnostics sector, Abbott provides comprehensive solutions for disease detection, monitoring, and treatment decision-making. The Diagnostic Products segment encompasses advanced systems and tests utilized across various healthcare settings, from hospitals to home care environments.
Key Offerings:
- Immunoassay Systems: Abbott’s ARCHITECT® and AxSYM® systems are utilized for immunoassays that measure hormone levels, infectious disease markers, and indicators of cardiac health, enabling timely and accurate diagnoses.
- Chemistry Systems: With instruments like the ARCHITECT® c8000, Abbott provides advanced chemistry analyzers that deliver crucial results for biochemical markers, facilitating the diagnosis of numerous health conditions.
- Molecular Diagnostics: Through innovative partnerships, Abbott has developed a variety of molecular tests that identify genetic markers for diseases across its Vysis® product line, notably enhancing cancer diagnostics.
- Point-of-Care Systems: The i-STAT® system allows for rapid testing at the bedside or emergency setting, providing immediate results critical for effective medical decision-making.
- Diabetes Monitoring: The FreeStyle® product line consists of blood glucose monitoring systems designed for effective diabetes management. This includes meters, test strips, and data management software, all aimed at supporting individuals with diabetes.
Nutritional Products
Abbott’s Nutritional Products segment focuses on delivering tailored nutritional solutions to meet diverse consumer needs. This includes offerings for pediatric, adult, and clinical nutrition, ensuring that various dietary requirements are met.
Key Offerings:
- Infant Nutrition: The Enfamil® brand serves as a cornerstone within Abbotts nutritional portfolio, offering infant formulas that support growth and brain development.
- Adult Nutrition: Products like Ensure® are crafted for adults who require nutritional support for various reasons, such as weight management, enhancing general health, or facilitating recovery from medical conditions.
- Medical Nutrition: Abbott develops specialized nutritional products tailored for patients with specific medical conditions that require dietary intervention, ensuring holistic care.
Vascular Products
The Vascular Products segment focuses on devices and therapies designed to treat cardiovascular diseases through minimally invasive procedures. Abbott has established itself as an innovator in the field of stenting and vascular interventions.
Key Offerings:
- Coronary Stents: The Xience V® drug-eluting stent exemplifies Abbott’s dedication to advancing cardiac care through technologies that mitigate the risk of restenosis, thus improving patient outcomes following coronary interventions.
- Endovascular Solutions: Abbotts offerings include carotid stent systems such as Acculink® and Accunet®, as well as vessel closure devices like StarClose®, all aimed at addressing vascular blockages effectively.
- Advanced Balloon Dilation Products: Products such as Voyager® are pivotal for procedures involving vascular dilation, ensuring enhanced blood flow in affected regions and improving overall treatment efficacy.
Conclusion
Abbott Laboratories stands out as a significant player in the global healthcare landscape, utilizing innovation and strategic collaborations to advance its extensive portfolio across pharmaceuticals, diagnostics, nutrition, and vascular solutions. The integration of cutting-edge technology and ongoing research efforts enables Abbott to tackle complex medical challenges, providing effective products and services that focus on improving health outcomes worldwide.
1. Pharmaceutical Products
Abbotts Pharmaceutical Products segment is foundational to its operations, offering a broad array of prescription medications for both adults and children. The pharmaceutical portfolio targets key therapeutic areas, including cardiovascular diseases, metabolic disorders, infectious diseases, and neurology.
Key Offerings:
- Cardiovascular Drugs: Abbott has collaborated with AstraZeneca to develop innovative lipid management therapies. Noteworthy products include a fixed-dose combination treatment featuring Crestor® (rosuvastatin) alongside Abbott’s Tricor® (fenofibrate) and the advanced fenofibrate, ABT 335. These therapies focus on managing cholesterol levels to reduce the risk of cardiovascular events.
- Diabetes Care: Abbott has made significant contributions to diabetes management through its range of injectable and oral medications, designed to assist patients with blood sugar control and improve overall metabolic health.
- Immunology and Infectious Diseases: The company provides a spectrum of therapies aimed at managing autoimmune diseases and various infectious diseases, contributing to enhanced patient outcomes in these critical areas.
- Biosimilars and Biologics: Abbott is active in the biosimilars market, working to deliver affordable alternatives to biologic therapies, thus increasing accessibility for patients requiring complex treatments.
Diagnostic Products
Operating as a leader in the diagnostics sector, Abbott provides comprehensive solutions for disease detection, monitoring, and treatment decision-making. The Diagnostic Products segment encompasses advanced systems and tests utilized across various healthcare settings, from hospitals to home care environments.
Key Offerings:
- Immunoassay Systems: Abbott’s ARCHITECT® and AxSYM® systems are utilized for immunoassays that measure hormone levels, infectious disease markers, and indicators of cardiac health, enabling timely and accurate diagnoses.
- Chemistry Systems: With instruments like the ARCHITECT® c8000, Abbott provides advanced chemistry analyzers that deliver crucial results for biochemical markers, facilitating the diagnosis of numerous health conditions.
- Molecular Diagnostics: Through innovative partnerships, Abbott has developed a variety of molecular tests that identify genetic markers for diseases across its Vysis® product line, notably enhancing cancer diagnostics.
- Point-of-Care Systems: The i-STAT® system allows for rapid testing at the bedside or emergency setting, providing immediate results critical for effective medical decision-making.
- Diabetes Monitoring: The FreeStyle® product line consists of blood glucose monitoring systems designed for effective diabetes management. This includes meters, test strips, and data management software, all aimed at supporting individuals with diabetes.
Nutritional Products
Abbott’s Nutritional Products segment focuses on delivering tailored nutritional solutions to meet diverse consumer needs. This includes offerings for pediatric, adult, and clinical nutrition, ensuring that various dietary requirements are met.
Key Offerings:
- Infant Nutrition: The Enfamil® brand serves as a cornerstone within Abbotts nutritional portfolio, offering infant formulas that support growth and brain development.
- Adult Nutrition: Products like Ensure® are crafted for adults who require nutritional support for various reasons, such as weight management, enhancing general health, or facilitating recovery from medical conditions.
- Medical Nutrition: Abbott develops specialized nutritional products tailored for patients with specific medical conditions that require dietary intervention, ensuring holistic care.
Vascular Products
The Vascular Products segment focuses on devices and therapies designed to treat cardiovascular diseases through minimally invasive procedures. Abbott has established itself as an innovator in the field of stenting and vascular interventions.
Key Offerings:
- Coronary Stents: The Xience V® drug-eluting stent exemplifies Abbott’s dedication to advancing cardiac care through technologies that mitigate the risk of restenosis, thus improving patient outcomes following coronary interventions.
- Endovascular Solutions: Abbotts offerings include carotid stent systems such as Acculink® and Accunet®, as well as vessel closure devices like StarClose®, all aimed at addressing vascular blockages effectively.
- Advanced Balloon Dilation Products: Products such as Voyager® are pivotal for procedures involving vascular dilation, ensuring enhanced blood flow in affected regions and improving overall treatment efficacy.
Conclusion
Abbott Laboratories stands out as a significant player in the global healthcare landscape, utilizing innovation and strategic collaborations to advance its extensive portfolio across pharmaceuticals, diagnostics, nutrition, and vascular solutions. The integration of cutting-edge technology and ongoing research efforts enables Abbott to tackle complex medical challenges, providing effective products and services that focus on improving health outcomes worldwide.